KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Shares Issued (2017 - 2025)

Twist Bioscience (TWST) has disclosed Shares Issued for 7 consecutive years, with $171000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Shares Issued fell 86.32% to $171000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $1.4 million, a 77.07% decrease, with the full-year FY2025 number at $9.3 million, up 31.59% from a year prior.
  • Shares Issued was $171000.0 for Q3 2023 at Twist Bioscience, down from $353000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $323.9 million in Q4 2020 to a low of -$314.8 million in Q1 2021.
  • A 5-year average of $28.3 million and a median of $1.2 million in 2022 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 936066.67% in 2019; the steepest drop was 385195.0% in 2019.
  • Twist Bioscience's Shares Issued stood at $48.0 million in 2019, then surged by 574.79% to $323.9 million in 2020, then crashed by 99.04% to $3.1 million in 2021, then tumbled by 80.55% to $604000.0 in 2022, then crashed by 71.69% to $171000.0 in 2023.
  • Per Business Quant, the three most recent readings for TWST's Shares Issued are $171000.0 (Q3 2023), $353000.0 (Q2 2023), and $251000.0 (Q1 2023).